Elizade University Researcher Publishes New Study Findings on Tuberculosis (Anti-Tuberculous Drug Copper Pyrazinamide: Synthesis, Characterization, Theoretical DFT, Bioactivity and Toxicity Studies in the Liver)

MLA

“Elizade University Researcher Publishes New Study Findings on Tuberculosis (Anti-Tuberculous Drug Copper Pyrazinamide: Synthesis, Characterization, Theoretical DFT, Bioactivity and Toxicity Studies in the Liver).” TB & Outbreaks Week, 11 July 2023, p. 868. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.756554937&authtype=sso&custid=ns315887.

APA

Elizade University Researcher Publishes New Study Findings on Tuberculosis (Anti-Tuberculous Drug Copper Pyrazinamide: Synthesis, Characterization, Theoretical DFT, Bioactivity and Toxicity Studies in the Liver). (2023, July 11). TB & Outbreaks Week, 868.

Chicago

TB & Outbreaks Week. 2023. “Elizade University Researcher Publishes New Study Findings on Tuberculosis (Anti-Tuberculous Drug Copper Pyrazinamide: Synthesis, Characterization, Theoretical DFT, Bioactivity and Toxicity Studies in the Liver),” July 11. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.756554937&authtype=sso&custid=ns315887.